| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8840839 | Neuroscience | 2018 | 13 Pages |
Abstract
The obtained data indicate that the increase in 5-HT1A-D2 receptor heteromerization is a common molecular characteristic of paroxetine and low-dose risperidone treatment.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Magdalena Kolasa, Joanna Solich, Agata Faron-Górecka, Dariusz Å»urawek, Paulina Pabian, Sylwia Åukasiewicz, Maciej KuÅmider, Kinga Szafran-Pilch, Marta Szlachta, Marta Dziedzicka-Wasylewska,